Vitamin D3 Supplementation for Heart Failure Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Heart FailureVitamin D DeficiencyCardiomyopathyCongestive Heart Failure
Interventions
DRUG

Placebo Comparator: Sugar Pill

Placebo will be given in identical gelcaps (as microcrystalline cellulose) as 2 per day for a period of 6 months.

DRUG

Vitamin D3 (cholecalciferol)

10,000 IU vitamin D3 will be given as 5000 IU gelcaps two per day for a period of 6 months.

Trial Locations (2)

59802

International Heart Institute of Montana, Missoula

Saint Patrick Hosptial, Missoula

All Listed Sponsors
collaborator

Saint Patrick Hospital

OTHER

lead

Heidi Moretti, MS, RD

OTHER

NCT01636570 - Vitamin D3 Supplementation for Heart Failure Patients | Biotech Hunter | Biotech Hunter